The director of the center for gene therapy at Nationwide Children's Hospital discussed the prospect of gene therapy approvals in Duchenne muscular dystrophy and the associated challenges that remain to be addressed.
Kevin Flanigan, MD
Advertisement
Articles by Kevin Flanigan, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Picks Abeona’s XLRS Gene Therapy ABO-503 for RDEA Pilot Program
2
Krystal Biotech’s Neurotrophic Keratitis Gene Therapy Viral Vector Secures FDA Platform Technology Designation
3
BLA for Rocket’s LAD-I Gene Therapy Under Review by FDA Again
4
